Cite
Winter MP, Koziński M, Kubica J, et al. Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls. Postepy Kardiol Interwencyjnej. 2015;11(4):259-80doi: 10.5114/pwki.2015.55596.
Winter, M. P., Koziński, M., Kubica, J., Aradi, D., & Siller-Matula, J. M. (2015). Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 11(4), 259-80. https://doi.org/10.5114/pwki.2015.55596
Winter, Max-Paul, et al. "Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls." Postepy w kardiologii interwencyjnej = Advances in interventional cardiology vol. 11,4 (2015): 259-80. doi: https://doi.org/10.5114/pwki.2015.55596
Winter MP, Koziński M, Kubica J, Aradi D, Siller-Matula JM. Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls. Postepy Kardiol Interwencyjnej. 2015;11(4):259-80. doi: 10.5114/pwki.2015.55596. Epub 2015 Jan 12. PMID: 26677375; PMCID: PMC4679793.
Copy
Download .nbib